October 22, 2020 — The potential impact of the patient-clinician relationship on a patient's response to treatment is widely accepted. But until now, little was known about which parts of the brain may play a role in that interaction and which specific behaviors can influence clinical response, which is critically important to optimizing patient-clinician interactions for clinical benefit.

October 22, 2020 — A new clinical guideline from the American Society for Radiation Oncology (ASTRO) provides guidance for physicians who use radiation therapy to treat patients with locally advanced rectal cancer.

October 21, 2020 — Quantib, a market leader in artificial intelligence solutions for radiology, today announced that it received FDA clearance for its prostate solution. The solution is a zero-footprint software providing a comprehensive and intuitive workflow for enhanced assessments and is paired with fast processing and image registration enabling real-time workflows. 

October 21, 2020 — According to an article in ARRS' American Journal of Roentgenology (AJR), secondary interpretations of body magnetic resonance imaging (MRI) at tertiary care centers identify a high rate of discrepancies — with primary errors being interpretive in origin — suggesting that subspecialty interpretations should be encouraged, and institutions should provide adequate resources for these interpretations to occur

October 21, 2020 — The BBC News reported that Luke Allard of Mill Houses, King's Lynn, died at Queen Elizabeth Hospital in March one day after being discharged. Allard, 28, had Marfan syndrome, a genetic disorder that can cause heart issues.

Transitioning to a new device vendor can provide improvements to outdated technology and workflow. It also requires a commitment to onboarding and training the technologists to properly operate any new device.

October 20, 2020 — A new multi-institutional study published in the journal Radiology identifies patterns in abnormal brain magnetic resonance imaging (MRI) findings in patients with COVID-19.

October 20, 2020 — Bioimaging technologies are the eyes that allow doctors to see inside the body in order to diagnose, treat, and monitor disease.

October 20, 2020 — Ezra, a NY-based startup transforming early cancer screening using magnetic resonance imaging (MRI), announced that it has received FDA 510(k) premarket authorization for its Artificial Intelligence, designed to decrease the cost of MRI-based cancer screening, assisting radiologists in their analysis of prostate MRI scans. It is the first prostate AI to be cleared by the FDA.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now